Navigation Links
SCM Microsystems Announces Results of Annual Meeting
Date:10/30/2009

SANTA ANA, Calif. and ISMANING, Germany, Oct. 30 /PRNewswire-FirstCall/ -- SCM Microsystems, Inc. (Nasdaq: SCMM) (Prime Standard: SMY), a leading provider of solutions for secure access, secure identity and secure exchange, announced today that its stockholders have approved an increase of the amount of common shares authorized during yesterday's annual meeting of stockholders.

At its annual meeting held on October 29, 2009, 61 percent of SCM's stockholders cast their votes and a majority followed the proposals of the Board of Directors to vote for all proposals. In addition to the election of directors, proposals included a 20 million share increase to the number of common shares authorized under the Company's Certificate of Incorporation, as well as a two million share increase in the number of shares reserved for issuance under the Company's 2007 Stock Option Plan.

Securing approval for these share increases enables SCM to continue to pursue mergers and acquisitions, which are an important component of the Company's growth strategy. SCM is focused on taking an active role in shaping the Identity Management and contactless markets through investments, consolidation with other providers and active promotion of the development of solutions that will enable these markets to grow.

"We are pleased that our stockholders have demonstrated their support for our growth strategy. The increase in our capital stock gives us more options in negotiating additional acquisitions and other transactions with attractive companies in our markets. With the increase of shares reserved for the 1997 Stock Option Plan, we can reward committee employees as well as recruit additional industry specialists for SCM," said Felix Marx, chief executive officer of SCM Microsystems. "We are grateful for the continued support of our stockholders
'/>"/>

SOURCE SCM Microsystems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology news :

1. Sun Microsystems and Aware, Inc. Announce Integration of Awares BioSP with Sun Identity Management Solutions
2. Fidelica Microsystems Announces Biometrically-Authenticated Smart Card
3. Columbia University Medical Center announces 2009 Katz Prizes in Cardiovascular Research
4. Synaptics Announces Put Option for 0.75% Convertible Senior Subordinated Notes Due 2024
5. DigitalPersona Announces Windows 7 Support for Its Enterprise, Developer and Consumer Products
6. Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming
7. NIH announces 115 awards to encourage high-risk research and innovation
8. IRSF announces funding of first clinical trial with disease-modifying therapy for Rett syndrome
9. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
10. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
11. Distinctive Voices@The Beckman Center announces fall lecture series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... San Diego, California, has been awarded an accreditation ... on results of a recent onsite inspection. ... this national recognition and congratulated for the "excellence ... GenWay Clinical Laboratory is one of nearly 7,000 ... Program, begun in the early 1960s, is recognized ...
(Date:12/15/2009)... found the fossil remains of a whale, 4.5 million years ... first time, the results of the decay and fossilisation process ... a baleen whale from the Mysticeti group. , This is ... a whale from the Lower Pliocene (five million years ago) ... first time that the results of the processes of fossilisation ...
(Date:12/15/2009)... model organism, but there are currently few resources ... blood-forming tissues in this species. A newly ... from Cold Spring Harbor Laboratory Press fills this ... protocols for the preparation, enumeration, and microscopic examination ... tissues in the mouse. The laboratory manual ...
Breaking Biology News(10 mins):Story of 4.5 million-year-old whale unveiled in Huelva 2Story of 4.5 million-year-old whale unveiled in Huelva 3New source of classical techniques for blood-based studies in the laboratory mouse 2Mylans Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla 28R 29 HIV Treatment 54751 1Mylans Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla 28R 29 HIV Treatment 54751 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 1Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 2Free Compirion Bed Flow Webinar Helps Improve Patient Flow From ED to Inpatient Units 54747 3Anthem Blue Cross and Blue Shield in New Hampshire Announces Decision to Cover H1N1 Vaccine Administration 54744 1Anthem Blue Cross and Blue Shield in New Hampshire Announces Decision to Cover H1N1 Vaccine Administration 54744 2
... -- 12 AUGUST 2008 -- More than 10,000 ... at the George R. Brown Convention Center in ... latest research and trends in energy, water resources, ... related disciplines. , This first-ever Joint Annual Meeting ...
... The first study to compare the performance of different ... Lady Bird Johnson Wildflower Center at The University of ... these roofs are created equal. , Interest in vegetated ... more important to property owners. Yet the study of ...
... wheat disease strain which could lead to a global wheat ... States, with funding from the Bill & Melinda Gates Foundation ... as part of the Durable Rust Resistance in Wheat project ... stem rust. , World leaders in rust research Dr ...
Other Biology News:Scientists team up in Houston to tackle global challenges 2Scientists team up in Houston to tackle global challenges 3Scientists team up in Houston to tackle global challenges 4Green roofs differ in building cooling, water handling capabilities 2Green roofs differ in building cooling, water handling capabilities 3CSIRO enlisted to avert global wheat supply crisis 2
(Date:12/15/2009)... Epeius Biotechnologies Corporation, an emerging leader in the ... of the cutting-edge science behind its lead oncology ... world rediscovered the Cyclin G1 gene ... and disease progression, and thus a prime target ... National Cancer Institute investigating the role of microRNAs ...
(Date:12/15/2009)... Repligen Corporation (Nasdaq: RGEN ) today announced ... funding to support the ongoing development of new ... Association (MDA). This grant will support the ... manufacture of a drug candidate for human clinical ... provides important funding for Repligen,s research but it ...
(Date:12/15/2009)... Reportlinker.com announces that a new market research ... The Future of Orphan Diseases ... Analysis and Reimbursement ,, ... Summary ,, The author has released ... Diseases Therapeutics - Market Forecasts to 2015, ...
(Date:12/15/2009)... WILMINGTON, Del. and CHARLOTTESVILLE, Va., Dec. 15 ... ) and the University of Virginia (UVa) ... entered into a strategic research collaboration to ... coronary artery disease (CAD) with a secondary ... (Logo: http://www.newscom.com/cgi-bin/prnh/20091027/PH99766LOGO ) ,, The ...
Breaking Biology Technology:Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 2Repligen Receives Second Research Grant from the Muscular Dystrophy Association to Support Friedreich's Ataxia Preclinical Development Program 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 2AstraZeneca and the University of Virginia Sign Strategic Research Collaboration to Develop Novel Treatments for Cardiovascular Disease 3
... Sept. 17 /Xinhua-PRNewswire/ -- Shandong Zhouyuan Seed,and Nursery ... "Parent,Corporation") which is incorporated in the State of ... Shandong Zhouyuan Seed and,Nursery Co., Ltd. ("Zhouyuan" or ... agreement with Linyi Kun Yuan Seeds Co., Ltd. ...
... HAMILTON, Bermuda, Sept. 17 Warner Chilcott,Limited (Nasdaq: ... has,received a non-final Action Closing Prosecution from the U.S. ... USPTO ordered a,reexamination of LEO,s US Patent No. 6,753,013 ... Galderma R&D. The 013 Patent covers TACLONEX,and certain of ...
... LMNX ) today announced that management will present at ... September,17-20, 2007, at the St. Regis Hotel in San ... president and chief,executive officer, will begin at 11:00 a.m. ... 2007. The presentation will be webcast live,and may be ...
Other Biology Technology:Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 2Shandong Zhouyuan Seed and Nursery Co., Ltd. Signs an Agreement with Linyi Company 3Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent 2Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent 3Luminex Corporation to Present at ThinkEquity Partners Investor Conference 2